MedElevator
Войти в исследования JMIR research protocols · 2026
Comparative Evaluation of AmnioGuard and Advanced Platelet-Rich Fibrin When Combined With NovaBone Putty in the Regeneration of Human Periodontal Infrabony Defects: Protocol for a Randomized Controlled Clinical Trial.
Протокол клинического исследованияСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bhandari Geeta, Jaiswal Priyanka, Bhagat Shweta, Kotecha Sakshi
Аннотация
BACKGROUND: Periodontitis causes progressive attachment loss, which in turn causes tooth mobility and, ultimately, tooth loss. Regenerating and rebuilding the lost periodontal tissue is the goal of periodontal regenerative surgery. Regeneration using AmnioGuard, advanced platelet-rich fibrin (A-PRF), and NovaBone Putty has been demonstrated to be successful in increasing clinical attachment level and decreasing probing pocket depth.
OBJECTIVE: This study aims to compare and evaluate the effectiveness of AmnioGuard and A-PRF membrane in combination with NovaBone Putty in the regeneration of human periodontal infrabony defects.
METHODS: A total of 24 patients will be selected and divided into 2 groups: group A (n=12, 50%) and group B (n=12, 50%). Group A will receive treatment with NovaBone Putty and AmnioGuard, whereas group B will receive treatment with autologous A-PRF and NovaBone Putty. Plaque index, clinical attachment level, probing pocket depth, complete mouth bleeding score, and intraoral periapical radiographs will be statistically analyzed. Clinical and radiographic features will be evaluated before surgery and 6 months following the procedure.
RESULTS: Recruitment began on September 16, 2025, and is ongoing. As of manuscript submission, 4 participants have been enrolled. Results are expected to be published in 2027. All the clinical measurements will be recorded after 6 months. It can be anticipated that AmnioGuard membrane with NovaBone Putty will provide additional benefits in the management of chronic periodontitis by promoting better healing and clinical outcomes.
CONCLUSIONS: Within the constraints of this study, the AmnioGuard membrane combined with NovaBone Putty may be more effective in the treatment of chronic periodontitis.
OBJECTIVE: This study aims to compare and evaluate the effectiveness of AmnioGuard and A-PRF membrane in combination with NovaBone Putty in the regeneration of human periodontal infrabony defects.
METHODS: A total of 24 patients will be selected and divided into 2 groups: group A (n=12, 50%) and group B (n=12, 50%). Group A will receive treatment with NovaBone Putty and AmnioGuard, whereas group B will receive treatment with autologous A-PRF and NovaBone Putty. Plaque index, clinical attachment level, probing pocket depth, complete mouth bleeding score, and intraoral periapical radiographs will be statistically analyzed. Clinical and radiographic features will be evaluated before surgery and 6 months following the procedure.
RESULTS: Recruitment began on September 16, 2025, and is ongoing. As of manuscript submission, 4 participants have been enrolled. Results are expected to be published in 2027. All the clinical measurements will be recorded after 6 months. It can be anticipated that AmnioGuard membrane with NovaBone Putty will provide additional benefits in the management of chronic periodontitis by promoting better healing and clinical outcomes.
CONCLUSIONS: Within the constraints of this study, the AmnioGuard membrane combined with NovaBone Putty may be more effective in the treatment of chronic periodontitis.